Literature DB >> 23877610

Expression and treatment of pain-related behavioral depression.

S Stevens Negus1.   

Abstract

Pain is often associated with clinically relevant depression of behavior and mood, and relief of pain-related depression is a common goal of treatment in both human and veterinary medicine. In the development of pharmacological compounds to treat pain and related depression, preclinical studies may be used to evaluate the analgesic potential of new drugs. Such studies require reliable, accurate assays of pain-related behavioral depression in animals. Intracranial self-stimulation (ICSS) is a type of operant conditioning procedure that produces stable baseline behavioral response rates. The author reviews recent research on the use of ICSS to evaluate the expression and pharmacological modulation of pain-related behavioral depression in rats. Results suggest that assays of pain-depressed behavior using ICSS may serve as a useful new tool to improve the translation of preclinical findings to clinical results in analgesic drug development.

Entities:  

Mesh:

Year:  2013        PMID: 23877610      PMCID: PMC5425249          DOI: 10.1038/laban.255

Source DB:  PubMed          Journal:  Lab Anim (NY)        ISSN: 0093-7355            Impact factor:   12.625


  42 in total

1.  The ventral striatum is implicated in the analgesic effect of mood changes.

Authors:  Chantal Villemure; Audrey C Laferrière; M Catherine Bushnell
Journal:  Pain Res Manag       Date:  2012 Mar-Apr       Impact factor: 3.037

2.  Behavioral effects of the delta-selective opioid agonist SNC80 and related compounds in rhesus monkeys.

Authors:  S S Negus; M B Gatch; N K Mello; X Zhang; K Rice
Journal:  J Pharmacol Exp Ther       Date:  1998-07       Impact factor: 4.030

Review 3.  Determinants of the specificity of behavioral effects of drugs.

Authors:  R T Kelleher; W H Morse
Journal:  Ergeb Physiol       Date:  1968

Review 4.  Prescription opioid abuse, pain and addiction: clinical issues and implications.

Authors:  Walter Ling; Larissa Mooney; Maureen Hillhouse
Journal:  Drug Alcohol Rev       Date:  2011-05

Review 5.  Role of central dopamine in pain and analgesia.

Authors:  Patrick B Wood
Journal:  Expert Rev Neurother       Date:  2008-05       Impact factor: 4.618

6.  Preclinical evaluation of the abuse potential of the analgesic bicifadine.

Authors:  Katherine L Nicholson; Robert L Balster; Krystyna Golembiowska; Magdalena Kowalska; Joseph P Tizzano; Phil Skolnick; Anthony S Basile
Journal:  J Pharmacol Exp Ther       Date:  2009-04-08       Impact factor: 4.030

7.  The oral analgesic efficacy of bicifadine hydrochloride in postoperative pain.

Authors:  R I Wang; R P Johnson; J C Lee; E M Waite
Journal:  J Clin Pharmacol       Date:  1982-04       Impact factor: 3.126

8.  Effects of laparotomy on spontaneous exploratory activity and conditioned operant responding in the rat: a model for postoperative pain.

Authors:  Thomas J Martin; Nancy L Buechler; William Kahn; James C Crews; James C Eisenach
Journal:  Anesthesiology       Date:  2004-07       Impact factor: 7.892

9.  Effects of kappa opioids in an assay of pain-depressed intracranial self-stimulation in rats.

Authors:  S Stevens Negus; Ember M Morrissey; Marisa Rosenberg; K Cheng; Kenner C Rice
Journal:  Psychopharmacology (Berl)       Date:  2010-01-26       Impact factor: 4.530

Review 10.  Pain-like behaviours in animals - how human are they?

Authors:  Gordon Blackburn-Munro
Journal:  Trends Pharmacol Sci       Date:  2004-06       Impact factor: 14.819

View more
  28 in total

1.  Effects of the noncompetitive N-methyl-d-aspartate receptor antagonists ketamine and MK-801 on pain-stimulated and pain-depressed behaviour in rats.

Authors:  T M Hillhouse; S S Negus
Journal:  Eur J Pain       Date:  2016-02-23       Impact factor: 3.931

Review 2.  Pros and Cons of Clinically Relevant Methods to Assess Pain in Rodents.

Authors:  Anke Tappe-Theodor; Tamara King; Michael M Morgan
Journal:  Neurosci Biobehav Rev       Date:  2019-03-15       Impact factor: 8.989

Review 3.  Intracranial self-stimulation to evaluate abuse potential of drugs.

Authors:  S Stevens Negus; Laurence L Miller
Journal:  Pharmacol Rev       Date:  2014-07       Impact factor: 25.468

4.  Analysis of inflammation-induced depression of home cage wheel running in rats reveals the difference between opioid antinociception and restoration of function.

Authors:  Ram Kandasamy; Jonas J Calsbeek; Michael M Morgan
Journal:  Behav Brain Res       Date:  2016-10-13       Impact factor: 3.332

5.  Repeated Morphine Produces Sensitization to Reward and Tolerance to Antiallodynia in Male and Female Rats with Chemotherapy-Induced Neuropathy.

Authors:  L P Legakis; S S Negus
Journal:  J Pharmacol Exp Ther       Date:  2018-01-23       Impact factor: 4.030

6.  Lack of paclitaxel effects on intracranial self-stimulation in male and female rats: comparison to mechanical sensitivity.

Authors:  Luke P Legakis; John W Bigbee; S Stevens Negus
Journal:  Behav Pharmacol       Date:  2018-04       Impact factor: 2.293

7.  Effects of μ-opioid receptor agonists in assays of acute pain-stimulated and pain-depressed behavior in male rats: role of μ-agonist efficacy and noxious stimulus intensity.

Authors:  Ahmad A Altarifi; Kenner C Rice; S Stevens Negus
Journal:  J Pharmacol Exp Ther       Date:  2014-11-18       Impact factor: 4.030

8.  Effects of repeated treatment with monoamine-transporter-inhibitor antidepressants on pain-related depression of intracranial self-stimulation in rats.

Authors:  L P Legakis; L Karim-Nejad; S S Negus
Journal:  Psychopharmacology (Berl)       Date:  2020-05-08       Impact factor: 4.530

9.  Pain-related depression of the mesolimbic dopamine system in rats: expression, blockade by analgesics, and role of endogenous κ-opioids.

Authors:  Michael D Leitl; Sara Onvani; M Scott Bowers; Kejun Cheng; Kenner C Rice; William A Carlezon; Matthew L Banks; S Stevens Negus
Journal:  Neuropsychopharmacology       Date:  2013-09-06       Impact factor: 7.853

10.  Effects of the fatty acid amide hydrolase inhibitor URB597 on pain-stimulated and pain-depressed behavior in rats.

Authors:  Andrew J Kwilasz; Rehab A Abdullah; Justin L Poklis; Aron H Lichtman; Sidney S Negus
Journal:  Behav Pharmacol       Date:  2014-04       Impact factor: 2.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.